Búsqueda | Portal de Búsqueda de la BVS España

1.

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.

Burge, R T; Disch, D P; Gelwicks, S; Zhang, X; Krege, J H.

Osteoporos Int; 28(3): 799-809, 2017 03.

Artículo en Inglés | MEDLINE | ID: mdl-28028555

2.

Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.

Ryan, C; Guenther, L; Foley, P; Weisman, J; Burge, R T; Gallo, G; See, K; McKean-Matthews, M; Bertram, C C; Merola, J F.

J Eur Acad Dermatol Venereol; 36(4): e277-e279, 2022 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-34812561

3.

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.

Harvey, N C; Kanis, J A; Odén, A; Burge, R T; Mitlak, B H; Johansson, H; McCloskey, E V.

Osteoporos Int; 26(11): 2677-84, 2015 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26092063

4.

The impact of teriparatide adherence and persistence on fracture outcomes.

Yu, S; Burge, R T; Foster, S A; Gelwicks, S; Meadows, E S.

Osteoporos Int; 23(3): 1103-13, 2012 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-22159748

5.

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Hadji, P; Zanchetta, J R; Russo, L; Recknor, C P; Saag, K G; McKiernan, F E; Silverman, S L; Alam, J; Burge, R T; Krege, J H; Lakshmanan, M C; Masica, D N; Mitlak, B H; Stock, J L.

Osteoporos Int; 23(8): 2141-50, 2012 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-22159672

6.

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.

Pike, C; Birnbaum, H G; Schiller, M; Swallow, E; Burge, R T; Edgell, E T.

Osteoporos Int; 22(1): 47-56, 2011 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-20490782

7.

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US.

Pike, C T; Birnbaum, H G; Schiller, M; Swallow, E; Burge, R T; Edgell, E T.

Osteoporos Int; 22(10): 2611-21, 2011 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-21107532

8.

Teriparatide fracture effectiveness in the real world.

Krege, J H; Burge, R T; Marin, F.

Osteoporos Int; 26(8): 2217-8, 2015 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-25906242

9.

Metabolic Disorders, Osteoporosis and Fracture Risk in Asia: A Systematic Review.

Sugimoto, T; Sato, M; Dehle, F C; Brnabic, A J M; Weston, A R; Burge, R T.

Value Health; 17(7): A772, 2014 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-27202845

10.

Allocating practice expense under the Medicare fee schedule.

Pope, G C; Burge, R T.

Health Care Financ Rev; 14(3): 139-62, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-10130574

11.

Diffusion of Medicare's RBRVS and related physician payment policies.

McCormack, L A; Burge, R T.

Health Care Financ Rev; 16(2): 159-73, 1994.

Artículo en Inglés | MEDLINE | ID: mdl-10142370

12.

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer.

Ivergård, M; Ström, O; Borgström, F; Burge, R T; Tosteson, A N A; Kanis, J.

Bone; 47(5): 966-74, 2010 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-20691296

13.

Economies of scale in physician practice.

Pope, G C; Burge, R T.

Med Care Res Rev; 53(4): 417-40, 1996 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-10162959

14.

One year outcomes and costs following a vertebral fracture.

Lindsay, R; Burge, R T; Strauss, D M.

Osteoporos Int; 16(1): 78-85, 2005 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-15167988

15.

Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.

King, Alison B; Saag, K G; Burge, R T; Pisu, M; Goel, N.

Osteoporos Int; 16(12): 1545-57, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-15942702

16.

Resource-based relative-value scale expansion: implications for performance and quality of care.

Burge, R T.

Clin Perform Qual Health Care; 5(1): 5-10, 1997.

Artículo en Inglés | MEDLINE | ID: mdl-10165000

17.

Inefficiencies in physician practices.

Pope, G C; Burge, R T.

Adv Health Econ Health Serv Res; 13: 129-64, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-10129441

18.

Hospital care of osteoporosis-related vertebral fractures.

Gehlbach, S H; Burge, R T; Puleo, E; Klar, J.

Osteoporos Int; 14(1): 53-60, 2003 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-12577185

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.

Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.

The impact of teriparatide adherence and persistence on fracture outcomes.

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US.

Teriparatide fracture effectiveness in the real world.

Metabolic Disorders, Osteoporosis and Fracture Risk in Asia: A Systematic Review.

Allocating practice expense under the Medicare fee schedule.

Diffusion of Medicare's RBRVS and related physician payment policies.

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer.

Economies of scale in physician practice.

One year outcomes and costs following a vertebral fracture.

Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.

Resource-based relative-value scale expansion: implications for performance and quality of care.

Inefficiencies in physician practices.

Hospital care of osteoporosis-related vertebral fractures.